PharVision Advisers’s Meta Platforms (Facebook) META Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-428
Closed -$314K 887
2025
Q3
$314K Sell
428
-416
-49% -$310K 0.18% 202
2025
Q2
$623K Buy
844
+440
+109% +$272K 0.89% 2
2025
Q1
$233K Sell
404
-1,086
-73% -$701K 0.32% 151
2024
Q4
$872K Buy
+1,490
New +$875K 0.74% 7

Other funds holding META

PharVision Advisers's META Position: Q4 2025 in Review

PharVision Advisers sold out of Meta Platforms (Facebook) (META) in Q4 2025, closing a stake of 428 shares — an estimated $314K sold.

PharVision Advisers first reported a position in META in Q4 2024 and held it in 4 quarters. The position peaked at $872K in Q4 2024. 5,140 funds tracked by Wall St. Rank hold META as of Q4 2025.

  • PharVision Advisers reported no remaining Meta Platforms (Facebook) position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 428 Meta Platforms (Facebook) shares in Q4 2025, an estimated $314K.
  • PharVision Advisers first reported a position in Meta Platforms (Facebook) in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Meta Platforms (Facebook) position peaked at $872K in Q4 2024.
  • 5,140 funds tracked by Wall St. Rank held Meta Platforms (Facebook) as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.